Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: Results from a nationwide one-day point prevalence of 329 German hospitals

Table 3 Prevalence rates of MDROs divided by screening strategy (non-overlapping Cis marked with *)

Screening for	MDRO	Screening			No screening
Screening for	MDRO	Number of hospitals	Mean prevalence [95 % CI]		Number of hospitals	Mean prevalence [95 % CI]
MRSA	MRSA	324	1.64	[1.46 – 1.82]	5	0.89	[-0.95 – 2.72]
- MRSA (all universal)		22	2.49	[1.59 – 3.40]
- MRSA (risk based – KRINKO)		261	1.59	[1.39 – 1.79]
- MRSA (risk based - in-house regime)		10	1.65	[0.83 – 2.47]
- not reported		31	1.55	[0.86 – 2.24]
ESBL	3MRGN-EC	72	1.27	[0.83 – 1.71]*	257	0.60	[0.46 – 0.73]	*
	3MRGN-KS		0.40	[0.14 – 0.66]		0.17	[0.12 – 0.22]
	3MRGN-ES		0.24	[0.03 – 0.45]		0.06	[0.04 – 0.09]
	3MRGN-AB		0.01	[-0.01 – 0.03]		0.02	[0.00 – 0.04]
	3MRGN-PS		0.52	[0.04 – 0.99]		0.12	[0.08 – 0.16]
VRE	VRE	69	0.70	[0.17 – 1.23]	260	0.13	[0.08 – 0.18]
4MRGN	4MRGN-EC	126	0.01	[-0.00 – 0.03]	203	0.01	[-0.01 – 0.03]
	4MRGN-KS		0.09	[-0.01 – 0.19]**		0.00	[-0.00 – 0.01]	**
	4MRGN-ES		0.02	[0.00 – 0.04]		0.00	[-0.00 – 0.01]
	4MRGN-AB		0.03	[0.00 – 0.06]		0.02	[0.00 – 0.03]
	4MRGN-PS		0.34	[0.05 – 0.63]		0.07	[0.03 – 0.10]

ISSN: 1471-2334